(Q74292805)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Risk group stratification in patients undergoing permanent (125)I prostate brachytherapy as monotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Young Kwok

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Steven J DiBiase

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pradip P Amin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Michael Naslund

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Geoffrey Sklar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Stephen C Jacobs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

588-594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Modern prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Palladium-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Spacing nomograph for interstitial implants of 125 I seeds

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

High dose combination radiotherapy for the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902796-7

7 January 2021

10.1016/S0360-3016(02)02796-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062601%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference